Literature DB >> 28099668

Developing Better Pneumococcal Vaccines for Adults.

Daniel M Weinberger1, Zitta B Harboe2, Eugene D Shapiro3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28099668      PMCID： PMC5568894          DOI： 10.1001/jamainternmed.2016.8289

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  8 in total

Review 1.  Reconsidering Guidelines on the Use of Pneumococcal Vaccines in Adults 65 Years or Older.

Authors:  Michael Hochman; Pieter A Cohen
Journal:  JAMA Intern Med       Date:  2015-12       Impact factor: 21.873

2.  Aging population and future burden of pneumococcal pneumonia in the United States.

Authors:  Peter C Wroe; Jonathan A Finkelstein; G Thomas Ray; Jeffrey A Linder; Kristen M Johnson; Sheryl Rifas-Shiman; Matthew R Moore; Susan S Huang
Journal:  J Infect Dis       Date:  2012-03-23       Impact factor: 5.226

3.  Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

Authors:  Marc J M Bonten; Susanne M Huijts; Marieke Bolkenbaas; Chris Webber; Scott Patterson; Samantha Gault; Cornelis H van Werkhoven; Anna M M van Deursen; Elisabeth A M Sanders; Theo J M Verheij; Michael Patton; Anne McDonough; Anita Moradoghli-Haftvani; Helen Smith; Tracey Mellelieu; Michael W Pride; Graham Crowther; Beate Schmoele-Thoma; Daniel A Scott; Kathrin U Jansen; Rita Lobatto; Bas Oosterman; Nils Visser; Esther Caspers; Andre Smorenburg; Emilio A Emini; William C Gruber; Diederick E Grobbee
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

4.  Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children.

Authors:  Riyadh D Muhammad; Reena Oza-Frank; Elizabeth Zell; Ruth Link-Gelles; K M Venkat Narayan; William Schaffner; Ann Thomas; Catherine Lexau; Nancy M Bennett; Monica M Farley; Lee H Harrison; Arthur Reingold; James Hadler; Bernard Beall; Keith P Klugman; Matthew R Moore
Journal:  Clin Infect Dis       Date:  2012-11-15       Impact factor: 9.079

Review 5.  Pneumococcal Prevention Gets Older and Wiser.

Authors:  Anne Schuchat
Journal:  JAMA Intern Med       Date:  2015-12       Impact factor: 21.873

Review 6.  Vaccines for preventing pneumococcal infection in adults.

Authors:  S A Moberley; J Holden; D P Tatham; R M Andrews
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

7.  Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-06-28       Impact factor: 17.586

8.  Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Sara Tomczyk; Nancy M Bennett; Charles Stoecker; Ryan Gierke; Matthew R Moore; Cynthia G Whitney; Stephen Hadler; Tamara Pilishvili
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-09-19       Impact factor: 17.586
  8 in total
  3 in total

1.  Beyond efficacy: A career evaluating the effectiveness of vaccines.

Authors:  Eugene Shapiro
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

Review 2.  Streptococcus pneumoniae's Virulence and Host Immunity: Aging, Diagnostics, and Prevention.

Authors:  Lavida R K Brooks; George I Mias
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

3.  Economic Burden of Pneumococcal Disease in Individuals Aged 15 Years and Older in the Liguria Region of Italy.

Authors:  Matteo Astengo; Chiara Paganino; Daniela Amicizia; Cecilia Trucchi; Federico Tassinari; Camilla Sticchi; Laura Sticchi; Andrea Orsi; Giancarlo Icardi; Maria Francesca Piazza; Bruno Di Silverio; Arijita Deb; Francesca Senese; Gian Marco Prandi; Filippo Ansaldi
Journal:  Vaccines (Basel)       Date:  2021-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.